Pabron Gold A Granules (パブロンゴールドA<微粒>): ingredients, dose and warnings in English
Pabron Gold A Granules (パブロンゴールドA<微粒>) is sold in Japan as a designated class 2 medicine: the box reads 第②類医薬品. The maker writes the name in English as PABRON GOLD A <GRANULES>. In 1 sachet (0.96 g): Guaifenesin 60 mg, Dihydrocodeine Phosphate 8 mg, dl-Methylephedrine Hydrochloride 20 mg, Acetaminophen 300 mg, Chlorpheniramine Maleate 2.5 mg, Anhydrous Caffeine 25 mg and 1 more. The package insert sets the adult dose at 1 sachet, 3 times a day, for ages 12 and over.
第②類医薬品 · Designated class 2要確認 · Shop checks first
What is in Pabron Gold A Granules
The package insert lists 7 active ingredients in 1 sachet (0.96 g). The middle column is how each one is written on the Japanese box.
| Ingredient | Name on the box | Amount |
|---|---|---|
| Guaifenesin | グアイフェネシン | 60 mg |
| Dihydrocodeine Phosphate | ジヒドロコデインリン酸塩 | 8 mg |
| dl-Methylephedrine Hydrochloride | dl-メチルエフェドリン塩酸塩 | 20 mg |
| Acetaminophen | アセトアミノフェン | 300 mg |
| Chlorpheniramine Maleate | クロルフェニラミンマレイン酸塩 | 2.5 mg |
| Anhydrous Caffeine | 無水カフェイン | 25 mg |
| Riboflavin | リボフラビン | 4 mg |
Additives, as written on the package insert (Japanese)
セルロース,無水ケイ酸,バレイショデンプン,D-マンニトール,ヒドロキシプロピルセルロース,メタケイ酸アルミン酸Mg,アスパルテーム(L-フェニルアラニン化合物),香料,バニリン
The maker publishes an English package insert for PABRON GOLD A : Taisho Pharmaceutical: PABRON GOLD A (English package insert). This page translates the current Japanese package insert on PMDA.
Source: PMDA (Pharmaceuticals and Medical Devices Agency) — パブロンゴールドA: package insert (添付文書) · Taisho Pharmaceutical — PABRON GOLD A : English package insert
What the package insert lists it for
The approved wording of the Japanese package insert, translated. It is what the product is sold for, not advice on what to take.
- Relief of the various symptoms of a cold (cough, phlegm, sore throat, sneezing, runny nose, blocked nose, chills, fever, headache, joint pain, muscle pain)
The dose, as written on the package insert
Translated line by line from the directions and dosage (用法・用量) section.
- Acetaminophen per dose
- 300 mg
- Adult dose
- 1 sachet
- Doses a day
- 3
- Age
- 12 and over
- Take the following amount after a meal, preferably within 30 minutes, with water or lukewarm water.
| Age | Single dose | Number of doses |
|---|---|---|
| 15 and over | 1 sachet | 3 times a day |
| 12 to 14 | 2/3 sachet | 3 times a day |
| Under 12 | Do not take |
Notes on the directions
- (1) Follow the directions and dosage exactly as specified.
- (2) When giving it to children, have them take it under the guidance and supervision of a parent or guardian.
Do not
The package insert opens with what you must not do.
(If you do not follow these, your current symptoms may get worse, and side effects or accidents become more likely)
1. Do not take it if you are one of the following people
- (1) People who have had allergic symptoms caused by this medicine or its ingredients.
- (2) People who have developed asthma after taking this medicine, or other cold medicines or pain and fever medicines.
- (3) Children under 12.
2. Do not use any of the following medicines while taking this medicine
- Other cold medicines, pain and fever medicines, sedatives, cough medicines, oral medicines containing antihistamines, etc. (oral medicines for rhinitis, motion sickness medicines, allergy medicines, etc.)
3. Do not drive or operate machinery after taking it
- (Drowsiness etc. may occur)
4. Women who are breastfeeding: do not take this medicine, or avoid breastfeeding if you take it
5. Do not drink alcohol before or after taking it
6. Do not keep taking it for a long time
7. Do not take an excessive amount
Ask a doctor, pharmacist or registered salesperson
The package insert says to ask for advice in these cases.
1. If you are one of the following people, ask a doctor, pharmacist or registered salesperson for advice before taking it
- (1) People who are receiving treatment from a doctor or dentist.
- (2) Women who are pregnant or think they may be pregnant.
- (3) Older people.
- (4) People who have had allergic symptoms caused by medicines etc.
- (5) People who have the following symptoms.
- High fever, difficulty urinating
- (6) People who have been diagnosed with the following.
- Thyroid dysfunction, diabetes, heart disease, high blood pressure, liver disease, kidney disease, gastric/duodenal ulcer, glaucoma, respiratory dysfunction, obstructive sleep apnoea syndrome, obesity
2. If the following symptoms appear after taking it, they may be side effects, so stop taking it immediately and ask a doctor, pharmacist or registered salesperson for advice, taking this leaflet with you
Possible side effects, by part of the body
- Skin
- rash/redness, itching
- Digestive system
- nausea/vomiting, loss of appetite
- Nervous system
- dizziness
- Urinary system
- difficulty urinating
- Other
- excessive drop in body temperature
- In rare cases the following serious symptoms may occur. If they do, see a doctor immediately.
Rare but serious symptoms: name and signs
- Shock (anaphylaxis)
- right after taking it, itchy skin, hives, hoarseness, sneezing, itchy throat, difficulty breathing, palpitations, clouding of consciousness, etc. appear.
- Oculomucocutaneous syndrome (Stevens-Johnson syndrome), Toxic epidermal necrolysis, Acute generalised exanthematous pustulosis
- high fever, bloodshot eyes, eye discharge, sores on the lips, sore throat, widespread rash/redness on the skin, small bumps (small pustules) appearing on reddened skin, the whole body feeling tired, having no appetite, etc. continue or rapidly get worse.
- Drug-induced hypersensitivity syndrome
- the skin turning red over a wide area, a rash all over the body, fever, the body feeling tired, swelling of the lymph nodes (neck, armpits, groin, etc.), etc. appear.
- Liver dysfunction
- fever, itching, rash, jaundice (the skin and the whites of the eyes turn yellow), brown urine, tiredness all over the body, loss of appetite, etc. appear.
- Kidney disorder
- fever, rash, decreased amount of urine, oedema all over the body, tiredness all over the body, joint pain (aching joints), diarrhoea, etc. appear.
- Interstitial pneumonia
- shortness of breath/difficulty breathing when climbing stairs or exerting yourself a little, dry cough, fever, etc. are seen, and these appear suddenly or continue.
- Asthma
- wheezing or whistling sounds when breathing, difficulty breathing, etc. appear.
- Aplastic anaemia
- bruises, nosebleeds, bleeding gums, fever, the skin and mucous membranes looking pale, a feeling of fatigue, palpitations, shortness of breath, feeling unwell and light-headed, blood in the urine, etc. appear.
- Agranulocytosis
- sudden high fever, chills, sore throat, etc. appear.
- Respiratory depression
- shortness of breath, difficulty breathing, etc. appear.
3. The following symptoms may appear after taking it, so if these symptoms continue or get worse, stop taking it and ask a doctor, pharmacist or registered salesperson for advice, taking this leaflet with you
- Constipation, dry mouth, drowsiness
4. If your symptoms do not improve after taking it 5 to 6 times, stop taking it and ask a doctor, pharmacist or registered salesperson for advice, taking this leaflet with you
Who can sell it in Japan
The Pabron Gold A Granules box carries the class 第②類医薬品, which decides who may sell it.
- On the box
- 第②類医薬品 (Designated class 2). The box reads 第2類医薬品 with the 2 in a square, or 第②類医薬品.
- Who can sell it
- A pharmacist or a registered salesperson may sell it.
要確認: the shop checks before selling this one.Pabron Gold A Granules contains Dihydrocodeine Phosphate and dl-Methylephedrine Hydrochloride. From 1 May 2026, medicines taken by mouth with these ingredients are designated abuse-prevention medicines (指定濫用防止医薬品).
- The five classes on Japanese medicine boxes, side by side
- What the shop checks before selling Pabron Gold A Granules: age, pack size and ID
Source: e-Gov law search (Digital Agency, Japan) — Pharmaceutical and Medical Device Act (医薬品医療機器等法), current text · e-Gov law search (Digital Agency, Japan) — Enforcement Regulations of the Pharmaceutical and Medical Device Act (施行規則), current text · Ministry of Health, Labour and Welfare — Designated class 2 medicines (指定第2類医薬品について) · Ministry of Health, Labour and Welfare — Designated abuse-prevention medicines, Notice No. 32 of 2026 (告示第32号) · Ministry of Health, Labour and Welfare — Quantity for designated abuse-prevention medicines, Notice No. 33 of 2026 (告示第33号) · Ministry of Health, Labour and Welfare — Selling designated abuse-prevention medicines (医薬発1226第16号, 26 December 2025) · Ministry of Health, Labour and Welfare — Q&A on selling designated abuse-prevention medicines (30 January 2026)
Taking it home
Pabron Gold A Granules contains Dihydrocodeine Phosphate. South Korea, Taiwan, mainland China and Hong Kong each have official rules on this ingredient.
Frequently asked questions
How much Acetaminophen is in Pabron Gold A Granules?
300 mg in a dose of 1 sachet, according to the Japanese package insert.
How much Pabron Gold A Granules can an adult take in a day?
The package insert sets the adult dose at 1 sachet, 3 times a day.
Can children take Pabron Gold A Granules?
The package insert gives doses from age 12 and says it is not to be taken below that age.
Do I need a pharmacist to buy Pabron Gold A Granules?
Pabron Gold A Granules is a designated class 2 medicine (第②類医薬品). A pharmacist or a registered salesperson may sell it.
Why does the shop check before selling Pabron Gold A Granules?
It contains Dihydrocodeine Phosphate and dl-Methylephedrine Hydrochloride, two of the 8 ingredients that make a medicine taken by mouth a designated abuse-prevention medicine (指定濫用防止医薬品) from 1 May 2026. The shop gives the information in writing and checks what you have bought there and at other shops.
What is Pabron Gold A Granules called in Japanese?
パブロンゴールドA<微粒>. The Pabron Gold A Granules box also carries the class 第②類医薬品.
Related items
Package insert in Japanese: PMDA
Sources for this page
- PMDA (Pharmaceuticals and Medical Devices Agency) パブロンゴールドA<微粒>: package insert (添付文書)checked October 3, 2026
- Taisho Pharmaceutical PABRON GOLD A <GRANULES>: English package insertchecked October 3, 2026
- e-Gov law search (Digital Agency, Japan) Pharmaceutical and Medical Device Act (医薬品医療機器等法), current textchecked October 3, 2026
- e-Gov law search (Digital Agency, Japan) Enforcement Regulations of the Pharmaceutical and Medical Device Act (施行規則), current textchecked October 3, 2026
- Ministry of Health, Labour and Welfare Designated class 2 medicines (指定第2類医薬品について)checked October 3, 2026
- Ministry of Health, Labour and Welfare Designated abuse-prevention medicines, Notice No. 32 of 2026 (告示第32号)checked October 3, 2026
- Ministry of Health, Labour and Welfare Quantity for designated abuse-prevention medicines, Notice No. 33 of 2026 (告示第33号)checked October 3, 2026
- Ministry of Health, Labour and Welfare Selling designated abuse-prevention medicines (医薬発1226第16号, 26 December 2025)checked October 3, 2026
- Ministry of Health, Labour and Welfare Q&A on selling designated abuse-prevention medicines (30 January 2026)checked October 3, 2026
Compiled by Japan Japan !! · Updated October 3, 2026